Ozempic & GLP-1 Weight Loss Drug Lawsuit Attorneys Home \ New York Personal Injury Lawyer \ New York Ozempic & GLP-1 Weight Loss Drug Lawsuit Attorneys John Richmond, Co-Founder and CEO June 18, 2026 Recent scientific studies and thousands of reported cases have linked popular GLP-1 receptor agonist medicationsoriginally designed for Type 2 diabetes but widely prescribed for weight lossto life-altering side effects
Biocare Blog Expert nutrition tips, side-effect relief strategies, and answers to your GLP-1 questions
New research began into the use of GLP-1 drugs for weight loss, and today we have several FDA-approved options
29. Di Bella, D., Lazzaro, F., Brusco, A., Plumari, M., Battaglia, G., Pastore, A., Finardi, A., Cagnoli, C., Tempia, F., Frontali, M., et al
Anti-inflammatory effect of Clostridium butyricum-derived extracellular vesicles in ulcerative colitis: Impact on host microRNAs expressions and gut microbiome profiles
Participants taking semaglutide 2.4 mg lost an average of 14.9% of body weight